Clinical trial

Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes

NCT00825643

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2008-04-01

PhaseN/A

Study timeline

Study start (unknown)2008-04-01Date precision: month

Registry last updated2017-02-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

insulin detemirDRUG · verified · RxNorm: insulin detemir

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

MadridSpain1 BeijingBeijing Municipality, China1 WarsawPoland1 IstanbulTurkey (Türkiye)1 MainzGermany1 RomeItaly1 Kfar SabaIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00825643 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.